Gepotidacin was non-inferior to ceftriaxone plus azithromycin for the primary outcome of microbiological success. 2. There were no serious or treatment-related adverse events in either group. Evidence ...

Quality of Life Matters: It Is Time to Integrate Scalp Cooling in Routine Clinical Practice There is a clear economic incentive for dose rounding down to a vial size to reduce product wastage.